Navigation Links
Peregrine Pharmaceuticals Forms Anti-Viral Research Group to Oversee Its Anti-PS Infectious Disease Collaborations
Date:10/7/2009

ists have also found that PS is exposed in certain infections caused by protozoan organisms, such as malaria and leishmaniasis.

Bavituximab, which is Peregrine's most advanced PS-targeting antibody, is currently being studied in a clinical trial for the treatment of patients co-infected with HCV and HIV. Phase I studies in HCV patients showed that bavituximab was well tolerated and it exhibited encouraging signs of anti-viral activity.

Peregrine's anti-PS antibodies are also generating positive data in preclinical HIV studies conducted by researchers from leading universities and medical research institutions in the U.S. and U.K. with funding from the Bill and Melinda Gates Foundation and the National Institutes of Allergy and Infectious Diseases (NIAID). These studies have yielded promising results that support the potential of PS-targeting agents for use as therapeutics, in vaccines and as topical microbicides, an especially promising application urgently needed in the effort to help women avoid infection with HIV and other sexually transmitted diseases such as herpes viruses and chlamydia. In addition, collaborators are also investigating the utility of PS-targeting antibodies against CMV infections and leishmaniasis, a protozoan disease that attacks people and cattle in tropical regions, with devastating effects on both health and economic well-being.

Under a major biodefense initiative funded by the Defense Threat Reduction Agency for the Transformational Medical Technologies Initiative (TMTI), bavituximab and a fully human equivalent antibody are in preclinical development for the treatment of viral hemorrhagic fevers under a contract worth up to $44.4 million. This contract, which is funding work at Peregrine and at several collaborating institutions, was awarded based on positive data from earlier studies in animals infected with VHF that was funded by a previous grant from NIAID. This work is going well, and Peregrine
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrines Cotara(R) for Treatment of Brain Cancer
2. Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials
3. Peregrine Pharmaceuticals Completes Patient Enrollment in its Phase II Trial of Bavituximab Plus Docetaxel in Breast Cancer Patients
4. Affitech-Discovered Anti-PS Antibodies in Development by Peregrine Pharmaceuticals Show Excellent Functionality in Preclinical Studies
5. Data Presented at AACR Annual Meeting Show Anti-Tumor Activity of Peregrines Fully Human Anti-PS Antibody in Prostate Cancer Model
6. Studies Presented at AACR Annual Meeting Highlight Multiple Immunomodulatory Mechanisms of Peregrines PS-Targeting Antibodies
7. Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial
8. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial
9. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
10. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
11. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... and MENLO PARK, Calif. ... Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the Company") today ... financial statements.  The Company recently changed its fiscal year ... application to list its common stock on a national ... DelMar,s financial statements as filed with the United States ...
(Date:8/29/2014)... , Industry professionals and ... Tweetchat taking place in real-time at CPhI Worldwide  ... UBM Live , announces the launch of ... of its kind global industry-wide Tweetchat for pharma ... aimed to stimulate conversations on key industry issues ...
(Date:8/28/2014)... & Long, P.A.: , Do you, or did ... , Did you purchase your shares before September 10, ... , Did you lose money in your investment in ... your rights? Rigrodsky & Long, P.A. ... MacFall , announces that a complaint has been filed in the ...
Breaking Medicine Technology:DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 3Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 2Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 3
(Date:8/29/2014)... effect, stimulating neurite extension in the presence ... enhancing nerve regeneration following nerve crush injury ... to stimulate nerve regeneration is limited because ... hypertension, and its considerable cost. With long-term ... drugs reportedly cause life-threatening infections. Like FK506, ...
(Date:8/29/2014)... As a chiropractic physician and medical doctor an ... direct connection between the condition of the feet and ... shoe inserts and orthotics weren’t satisfying my patients, I ... said. , Customizable to a user’s needs, the patent-pending ... in order to help prevent pain in the foot, ...
(Date:8/29/2014)... 29, 2014 (HealthDay News) -- The main strain ... Middle East and North Africa originated in sub-Saharan ... so-called community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) ... not recently been hospitalized. These infections typically affect ... contact or through touching contaminated objects such as ...
(Date:8/29/2014)... For the fifth year in a row, ... observing September 26th as Mesothelioma Awareness Day, by attending ... , Members of the community who wish to ... will be providing t-shirts and signs to participating community ... have received attention from Al Roker and ...
(Date:8/29/2014)... PreDiabetes Centers , the country’s leading prediabetes treatment company, ... a 20% discount off orders of $100 or more at ... shop, beginning September 1. , Keeping your body in ... chilly fall season. , Autumn’s cooler, cozier weather often invites ... the healthy salads and opt for creamy soups, hearty casseroles ...
Breaking Medicine News(10 mins):Health News: European MRSA Originated in Sub-Saharan Africa, Study Finds 2Health News:Organization to Raise Awareness of Mesothelioma on the Today Show 2Health News:PreDiabetes Centers Online Store Launches Fall Savings Event 2
... ... ... ... ...
... 2010) A new study, led by researchers at ... University Medical Center, demonstrates that acupuncture may be an ... cancer patients who are being treated with commonly used ... of Clinical Oncology . Joint pain and stiffness ...
... ... ... ... ...
... ... ... ... ...
... , ... a global leader of sea buckthorn berry based nutritional and personal care products, today announced ... and Sibu Beauty Sea Buckthorn Body Cream as complements to its existing portfolio of award-winning, ... Salt ...
... ... ... ... ...
Cached Medicine News:Health News:Salmonella Tennessee Identified in a Processed Food Ingredient 2Health News:Salmonella Tennessee Identified in a Processed Food Ingredient 3Health News:Salmonella Tennessee Identified in a Processed Food Ingredient 4Health News:Salmonella Tennessee Identified in a Processed Food Ingredient 5Health News:Salmonella Tennessee Identified in a Processed Food Ingredient 6Health News:Salmonella Tennessee Identified in a Processed Food Ingredient 7Health News:Acupuncture may relieve joint pain caused by some breast cancer treatments 2Health News:Psoriasis is More Than Skin Deep 2Health News:Psoriasis is More Than Skin Deep 3Health News:Psoriasis is More Than Skin Deep 4Health News:Psoriasis is More Than Skin Deep 5Health News:Psoriasis is More Than Skin Deep 6Health News:Psoriasis is More Than Skin Deep 7Health News:Psoriasis is More Than Skin Deep 8Health News:The SCOOTER Store Announces Coast-to-Coast Expansion of Local Stores 2Health News:The SCOOTER Store Announces Coast-to-Coast Expansion of Local Stores 3Health News:The SCOOTER Store Announces Coast-to-Coast Expansion of Local Stores 4Health News:Sibu Beauty Unveils Three New Products From Sea Buckthorn Berries – as Seen on The Doctors and The Dr. Oz Show 2Health News:Sibu Beauty Unveils Three New Products From Sea Buckthorn Berries – as Seen on The Doctors and The Dr. Oz Show 3Health News:Sibu Beauty Unveils Three New Products From Sea Buckthorn Berries – as Seen on The Doctors and The Dr. Oz Show 4Health News:Sibu Beauty Unveils Three New Products From Sea Buckthorn Berries – as Seen on The Doctors and The Dr. Oz Show 5Health News:DAV Recognizes President for Supporting Veterans Health Care Budget Reform 2Health News:DAV Recognizes President for Supporting Veterans Health Care Budget Reform 3Health News:DAV Recognizes President for Supporting Veterans Health Care Budget Reform 4
Ad-Techs Epidural Peg Electrodes feature a silicone-insulated titanium contact. To accommodate varying skull thicknesses, the post lengths range in length from 4 to 16 mm. The connecting lead wires e...
Integra Epilepsy grid electrodes are thin and flexible for easier placement and to conform to the curvature of the cortical surface. Lead tunneling is done using a 14-gauge tunneling needle (ET-2)....
... provide you with an alternative method for ... proven design as Ad-Techs Spencer Probe Depth ... an introducing needle instead of a stylet. ... 3 to 6 platinum recording contacts, 5.0 ...
... is designed for laboratories looking for time ... in system operation in terms of easy ... calibration and on-board stability., ,URISYS 2400 ... enhanced walk-away capability for medium to high ...
Medicine Products: